Use App
AI Agent
Trending
News
Earnings
All
DIA
2.08%
SPY
1.89%
QQQ
2.19%
Trending
ANT
14.52%
NBIS
8.80%
AMD
9.11%
BABA
0.79%
GME
2.00%
QQQ
2.19%
IREN
5.77%
SVRA
8.26%
VCX
19.85%
KLAR
11.77%
Feed
News
Sentiment
Earnings
Fundamentals
Info
Home
Symbol
CVM
News
Exchange:
NYSEMkt
·
Updated 03:30 PM EST
CVM News
News
all
press releases
CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month
Cel-Sci priced the share offering at $1, a 7.4% discount from the stock’s previous close.
Stocktwits
Full Article
Share to Feed
CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month
Cel-Sci priced the share offering at $1, a 7.4% discount from the stock’s previous close.
Stocktwits
Full Article
Share to Feed
More News
Why DID CVM Shares Rally Over 7% Today?
According to a filing with the U.S. Securities and Exchange Commission, CEO Kersten Geert R. purchased 38,023 shares in the company on Jan. 22 at $5.26 per share.
Stocktwits
Full Article
Retail Buzz Builds Around Cel-Sci Stock Ahead Of Saudi Ruling On Cancer Drug Multikine
Multikine is a cancer immunotherapy, which has significantly improved survival in head and neck cancer patients during global Phase 3 trials.
Stocktwits
Full Article
CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled
The formal agreement is expected to be signed with the Saudi pharmaceutical partner in the coming weeks, CEL-SCI said.
Stocktwits
Full Article
Cel-Sci Stock Slips After Public Offering: Retail's Neutral
The purchase price of each pre-funded Warrant is equal to the price per share of common stock being sold to the public in this offering, minus $0.01.
Stocktwits
Full Article
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile